Scotia Capital Inc. Bristol Myers Squibb CO Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Scotia Capital Inc. holds 206,460 shares of BMY stock, worth $11.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

206,460

Previous 171,703 20.24%

Holding current value

$11.9 Million

Previous $7.13 Million 49.85%

% of portfolio

0.06%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $1.38 Million - $1.8 Million	34,757 Added 20.24%	206,460 $10.7 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $5.21 Million - $6.86 Million	-129,514 Reduced 43.0%	171,703 $7.13 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $3.09 Million - $3.51 Million	64,493 Added 27.24%	301,217 $16.3 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $3.76 Million - $4.48 Million	77,471 Added 48.65%	236,724 $12.1 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $157,402 - $176,000	-2,719 Reduced 1.68%	159,253 $9.24 Million
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $3.16 Million - $3.51 Million	49,630 Added 44.18%	161,972 $10.4 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $584,819 - $663,317	8,900 Added 8.6%	112,342 $7.79 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $419,440 - $496,676	-6,125 Reduced 5.59%	103,442 $7.44 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $2,132 - $1.26 Million	-16,402 Reduced 13.02%	109,567 $7.79 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $2.49 Million - $2.74 Million	-34,280 Reduced 21.39%	125,969 $9.7 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $7.54 Million - $9.05 Million	-122,707 Reduced 43.37%	160,249 $11.7 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $1.09 Million - $1.27 Million	20,290 Added 7.72%	282,956 $17.6 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $2.52 Million - $2.95 Million	42,600 Added 19.36%	262,666 $15.5 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $804 - $876	13 Added 0.01%	220,066 $14.7 Million
Q1 2021 May 06, 2021	BUY	$59.34 - $66.74 $300,260 - $337,704	5,060 Added 2.35%	220,053 $13.9 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $1.52 Million - $1.73 Million	26,371 Added 13.98%	214,993 $13.3 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $261,363 - $289,625	4,551 Added 2.47%	188,622 $11.4 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $1.04 Million - $1.22 Million	18,989 Added 11.5%	184,071 $10.8 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $594,059 - $863,306	12,803 Added 8.41%	165,082 $9.2 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $1.75 Million - $2.29 Million	-35,600 Reduced 18.95%	152,279 $9.78 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $304,436 - $360,953	7,118 Added 3.94%	187,879 $9.53 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $3.77 Million - $4.17 Million	84,596 Added 87.97%	180,761 $8.2 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $13,761 - $16,409	305 Added 0.32%	96,165 $4.59 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $299,581 - $388,485	-6,144 Reduced 6.02%	95,860 $4.98 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1 Million - $1.13 Million	-18,156 Reduced 15.11%	102,004 $6.33 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $3,031 - $3,778	-60 Reduced 0.05%	120,160 $7.54 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $723,833 - $833,278	-12,080 Reduced 9.13%	120,220 $7.6 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $26,613 - $29,015	-444 Reduced 0.33%	132,300 $8.11 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $1.56 Million - $1.8 Million	-28,175 Reduced 17.51%	132,744 $8.46 Million
Q2 2017 Aug 15, 2017	BUY	N/A	160,919	160,919 $8.97 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Bristol Myers Squibb CO Transaction History